Effect of disease progression on the podocyte cell cycle in Alport Syndrome
Open Access
- 22 September 2021
- journal article
- research article
- Published by Elsevier BV in Kidney International
- Vol. 101 (1), 106-118
- https://doi.org/10.1016/j.kint.2021.08.026
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- Injection of Amniotic Fluid Stem Cells Delays Progression of Renal FibrosisJournal of the American Society of Nephrology, 2012
- Myc-dependent Mitochondrial Generation of Acetyl-CoA Contributes to Fatty Acid Biosynthesis and Histone Acetylation during Cell Cycle EntryOnline Journal of Public Health Informatics, 2010
- Renal Progenitor Cells Contribute to Hyperplastic Lesions of Podocytopathies and Crescentic GlomerulonephritisJournal of the American Society of Nephrology, 2009
- Cell-Cycle Control by Physiological Matrix Elasticity and In Vivo Tissue StiffeningCurrent Biology, 2009
- c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entryOncogene, 2009
- Recovery and maintenance of nephrin expression in cultured podocytes and identification of HGF as a repressor of nephrinAmerican Journal of Physiology-Renal Physiology, 2007
- Limitation of podocyte proliferation improves renal function in experimental crescentic glomerulonephritisKidney International, 2005
- Mouse Model of X-Linked Alport SyndromeJournal of the American Society of Nephrology, 2004
- Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: Role in podocyte proliferation and maturationKidney International, 2000
- Mitosis and the Presence of Binucleate Cells among Glomerular Podocytes in Diseased Human KidneysNephron, 1995